Burning Mouth Syndrome & Acid Reflux: The LPR Connection Explained

Burning mouth syndrome (BMS) is a chronic condition involving a persistent burning, scalding, or tingling sensation in the mouth — commonly affecting the tongue, gums, lips, inner cheeks, and roof of the mouth. It can also produce a dry mouth sensation, altered taste, or a bitter metallic taste in the background. What makes it genuinely difficult to manage is that the cause isn’t always obvious — and for a significant number of people, acid reflux and LPR (laryngopharyngeal reflux) are directly involved.

The connection between BMS and reflux is one that most doctors miss — partly because BMS is already poorly understood, and partly because LPR is frequently undiagnosed even when it’s the primary driver. Recent research has strengthened the link considerably: studies now show that LPR is present in the majority of BMS patients when properly tested, and that pepsin — the digestive enzyme carried up from the stomach in reflux — plays a central role in the nerve and tissue damage that triggers burning mouth symptoms.

This article covers what BMS actually is, how reflux causes it, what the research says, the other causes worth ruling out, and what you can do about it.

Key Takeaways

• Burning mouth syndrome causes persistent burning, tingling, or scalding in the mouth — affecting the tongue, gums, lips, palate, and sometimes throat — with symptoms typically worsening through the day.
• LPR (laryngopharyngeal reflux) is present in up to 93.8% of BMS patients when tested with proper impedance-pH monitoring, making it one of the most common underlying causes.
• Pepsin — the digestive enzyme carried up from the stomach in reflux — damages oral and throat nerve tissue directly, and gets reactivated by any acidic food or drink, perpetuating the burning cycle.
• PPIs alone are not effective for BMS driven by LPR — a 2022 study found 60.5% of BMS-GERD patients reported no benefit from PPIs, while alginate barrier therapy produced more consistent improvement.
• Salivary pepsin testing (Peptest) is emerging as a useful, non-invasive way to detect LPR-related BMS — patients with elevated salivary pepsin report significantly worse burning symptoms.
• Other BMS causes — nutritional deficiencies, allergies, hormonal changes, fungal infections, and medications — must be systematically ruled out to identify the root cause.
• Treatment works best when targeted at the confirmed underlying cause; reflux-driven BMS responds to dietary management and barrier therapy, while primary neuropathic BMS requires a different approach.
• Most GPs and dentists are unfamiliar with the LPR–BMS connection, which is why many patients go undiagnosed for years with inadequate treatment.

What Is Burning Mouth Syndrome?

Burning mouth syndrome is classified as a chronic orofacial pain disorder. The diagnostic hallmarks are a burning or dysaesthetic sensation in the mouth that recurs daily, lasts more than two hours per day, persists for at least three months, and occurs without any clinically identifiable causative lesion in the mouth — meaning there’s no visible wound, ulcer, or infection explaining the pain [Mun et al., Journal of Oral Medicine and Pain, 2022].

It goes by several other names: burning tongue syndrome, glossodynia (when the tongue is the primary site), and glossopyrosis. The burning can be localised to the tongue alone or spread to the entire oral cavity and throat. In some cases the sensation is more of a tingling or numbness rather than outright burning. A characteristic pattern is that symptoms are mild or absent in the morning and worsen progressively through the day — which is a useful diagnostic indicator.

BMS affects an estimated 0.7–5% of the population, with a significantly higher prevalence in postmenopausal women aged 50–70 [Mun et al., Journal of Oral Medicine and Pain, 2022]. However, it is not exclusively a condition of older women — it occurs across age groups and genders, and is frequently missed or misdiagnosed regardless of who has it. Research suggests the average diagnostic delay is considerable, partly because of how poorly the condition is understood across dentistry and primary care.

At the neurological level, BMS is now understood as primarily a neuropathic pain condition. Damage to the small nerve fibres in the oral mucosa — from whatever cause — results in abnormal sensory signalling. The nerves begin sending pain or burning signals even in the absence of an obvious stimulus. Think of it as a damaged alarm system that fires without an actual fire. The damage can also lower the threshold for pain, meaning that sensations that were previously neutral — temperature, mild acidity, even normal salivary contact — start to feel painful or burning [Klasser et al., Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017].

How Acid Reflux and LPR Cause Burning Mouth Syndrome

The link between acid reflux and BMS has been suspected for a long time, but the quality of evidence supporting it has grown dramatically in recent years — particularly with the use of modern impedance-pH monitoring that can detect all types of reflux events, including weakly acidic and non-acidic ones that older tests missed entirely.

A prospective study by Lechien and colleagues — one of the most rigorous investigations of this connection — enrolled 81 patients with primary BMS and put them through hypopharyngeal-esophageal impedance-pH monitoring (HEMII-pH). The results were striking: 76 out of 81 patients — 93.8% — had at least one pharyngeal reflux event detected. Of these, 46.1% were acid events, 31.6% were mixed, and 22.3% were non-acid. In other words, reflux — including types that PPIs don’t address — was present in virtually all patients with BMS who were properly tested [Lechien et al., Laryngoscope, 2021]. Patients who received treatment targeting their reflux type — diet, PPI, and alginate — saw significant improvement in their burning scores at three months, with 62.5% reporting meaningful improvement in mouth and tongue burning.

A 2024 scoping review covering 18 studies confirmed that LPR prevalence in burning mouth patients ranged from 50% to 93.8% — far higher than GERD alone (3.39%–23.4% in BMS patients) — underscoring that it’s specifically the pharyngeal and oral reach of reflux that matters here, not just stomach-level acid [Li et al., Oral Diseases, 2024].

Why Pepsin Is the Key Driver

The mechanism explaining why LPR causes BMS is increasingly well understood, and pepsin is at the centre of it. Pepsin is the protein-digesting enzyme produced by the stomach. When reflux carries it up past the upper esophageal sphincter into the throat and oral cavity, it doesn’t just cause irritation — it actively damages the mucosa and the small nerve fibres embedded within it.

Crucially, pepsin doesn’t need to arrive in strongly acidic reflux to cause this damage. It binds to tissue at the surface of the oral mucosa and sits there in a dormant state. Every subsequent exposure to acidic food or drink — even something with a mildly acidic pH — reactivates it and triggers another round of inflammatory damage. This cycle can continue indefinitely, even when stomach acid itself has been reduced by medication, because the pepsin is already at the site of the tissue.

A 2024 study by Lechien et al. measured salivary pepsin concentrations directly in BMS patients using Peptest and found that patients with higher salivary pepsin levels reported significantly worse burning mouth symptoms. Peptest positivity reached 86.8% in BMS patients who underwent salivary testing — making it a promising, non-invasive diagnostic marker for identifying which BMS patients have a reflux-related component [Lechien et al., European Archives of Otorhinolaryngology, 2024].

This helps explain a pattern many BMS sufferers will recognise: symptoms that fluctuate with diet, worsen after acidic foods or drinks, and don’t respond to standard pain treatments — because those treatments aren’t addressing the pepsin-mediated nerve damage driving the symptoms. You can read more about the pepsin mechanism in the context of LPR here.

Why PPIs Often Don’t Help with BMS

One of the most important clinical findings in the BMS-reflux literature is that PPIs alone typically fail to resolve BMS symptoms, even when reflux is the underlying cause. A 2022 clinical study found that 60.5% of BMS patients with confirmed GERD reported no benefit from PPI therapy. By contrast, 49.2% reported benefit from alginate barrier therapy (sodium alginate and sodium bicarbonate), with 28% showing near-complete remission on alginate alone [Russo et al., Acta Biomedica, 2022].

This makes pharmacological sense. PPIs reduce gastric acid production, but they don’t prevent reflux from occurring — and they do nothing to clear pepsin already present in oral tissues or to stop weakly acidic and non-acid reflux events, which were present in 53.9% of the LPR events detected in the Lechien study. Alginate, which forms a physical barrier at the top of the stomach and neutralises the acid pocket, provides more relevant protection against the pharyngeal and oral pepsin exposure that’s driving the nerve damage.

This is also consistent with the broader literature on why acid reflux medication often stops working — particularly for LPR patients whose symptoms are driven more by pepsin than by acid itself.

Other Causes of Burning Mouth Syndrome to Rule Out

Reflux and LPR are among the most common underlying causes of BMS — but they’re not the only ones. Accurate diagnosis depends on systematically working through the other possibilities, because the right treatment depends entirely on the right cause.

Nutritional Deficiencies

Several nutritional deficiencies are consistently associated with BMS. The most important ones to test for are iron, zinc, vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B6 (pyridoxine), vitamin B12, folate, and vitamin D. These nutrients are all directly involved in nerve function and oral mucosal integrity — deficiency in any of them can contribute to the abnormal sensory signalling that produces burning symptoms. Blood testing is the only reliable way to identify this as a cause. If you have confirmed LPR as well as nutritional deficiencies, both need to be addressed — they can compound each other. For more on the vitamin D connection specifically, see vitamin D and silent reflux.

Allergies and Contact Sensitisation

Allergic reactions — to food, food additives, oral care products (toothpaste, mouthwash), or dental materials (particularly nickel, cobalt, and acrylates in dentures) — can trigger burning mouth symptoms through local inflammatory and immune responses. Denture-related BMS is worth particular attention: a poor fit can also cause pressure-mediated nerve irritation independently of any allergenic component. If your BMS began after new dental work or a change in dental materials, this is the first place to look. Patch testing and food elimination can help identify the responsible agent.

Oral Fungal Infections

Oral candidiasis (thrush) can cause burning and discomfort that resembles BMS. It’s more common in people taking antibiotics, using inhaled corticosteroids, or who are immunocompromised. A visual examination and oral swab can identify or rule this out quickly. This is usually straightforward to treat once confirmed, so it should be excluded early in any BMS workup.

Hormonal Changes

The higher prevalence of BMS in postmenopausal women suggests a hormonal component. Declining oestrogen levels affect the oral mucosa and can alter pain thresholds — making the mouth more sensitive to stimuli that previously weren’t painful. Hormonal status is worth factoring in when BMS coincides with perimenopause or menopause.

Medications

A number of common medications list burning mouth or altered taste as side effects. ACE inhibitors (commonly prescribed for blood pressure) are the most well-documented offenders. Antiretrovirals, some anticonvulsants, and certain antidepressants have also been associated with BMS-type symptoms. If your BMS started shortly after beginning a new medication, that temporal connection is worth raising with your prescribing doctor.

Dry Mouth (Xerostomia)

Reduced saliva production — from medications, Sjögren’s syndrome, or mouth breathing — creates a hostile oral environment. Saliva has a protective and buffering role; without adequate saliva, the oral mucosa is more vulnerable to irritation and the pH of the oral environment shifts. Dry mouth and BMS frequently co-exist, and dry mouth can worsen BMS driven by other causes including reflux, since there’s less saliva to dilute pepsin deposits on oral tissue.

How to Tell If Reflux Is Driving Your BMS

If you have BMS and reflux is a potential contributor, there are a few useful signals to look for:

• Throat symptoms alongside mouth burning: LPR symptoms — chronic throat clearing, persistent cough, hoarseness, post-nasal drip sensation, globus (lump in throat feeling) — occurring alongside BMS are a significant indicator. Most people with reflux-driven BMS have some throat involvement too.
• Symptoms that fluctuate with diet: If your burning noticeably worsens after acidic foods, coffee, alcohol, or carbonated drinks, that’s consistent with pepsin reactivation — a core reflux mechanism.
• A bitter or sour taste: Tasting acid or bitter fluid at the back of the throat or mouth, especially after meals or on waking, is a direct sign of reflux reaching the oral cavity.
• No response to standard pain treatments: If BMS-specific treatments (topical clonazepam, capsaicin) haven’t worked and no obvious dental or nutritional cause has been found, reflux should be formally investigated.
• Worsening symptoms after lying down: Nocturnal or morning-predominant burning that worsens when lying flat is consistent with nighttime reflux events reaching the throat and mouth during sleep.

A practical first step is my Reflux Symptom Index (RSI) test, which can give you an indication of whether your overall symptom pattern matches LPR. For confirmed diagnosis, hypopharyngeal-esophageal impedance-pH monitoring (HEMII-pH) is the gold standard — it’s the test used in the research above that identified reflux in 93.8% of BMS patients.

Treatment: What Actually Works for Reflux-Related BMS

Treatment for BMS must be targeted at the underlying cause — there’s no single approach that works across all cases, which is partly why this condition has such a poor track record of resolution in general practice.

For reflux-driven BMS, the treatment logic follows the same principles as LPR management:

Reduce pepsin exposure at the oral mucosa

Since pepsin reactivation by dietary acid is the primary driver of ongoing tissue damage, eliminating low-pH foods and drinks (below pH 5) removes the trigger that keeps the cycle going. This includes citrus fruits and juices, tomatoes, vinegar, coffee, alcohol, and carbonated drinks. Alkaline water (pH 8.8+) is a useful addition — at this pH it can permanently deactivate pepsin it contacts, rather than just diluting it.

Use alginate barrier therapy

Given the evidence that PPIs largely fail in BMS-GERD patients while alginate shows more consistent benefit, an alginate-containing preparation taken after meals and before bed is a more logical pharmacological approach than PPI escalation alone. Products like Gaviscon Advance (UK formulation) form a raft at the gastroesophageal junction that physically limits the escape of pepsin-containing reflux into the oesophagus and throat.

Follow an LPR-appropriate dietary framework

The same dietary approach that reduces LPR throat symptoms applies directly to reflux-related BMS: smaller meals, elimination of LES-weakening foods, not eating within three hours of bed, and keeping a food and symptom diary during the initial weeks to map personal triggers. The complete LPR foods to avoid list is a practical starting reference.

Address nutritional deficiencies in parallel

Even when reflux is the primary driver, deficiencies in B vitamins, zinc, or vitamin D may compound nerve dysfunction and slow recovery. Testing and correcting any confirmed deficiencies is worthwhile alongside the dietary management.

If BMS has a primary neuropathic component

When reflux has been investigated and adequately addressed but burning symptoms persist, or when testing doesn’t support a reflux cause, the neuropathic dimension of BMS requires separate management. Current evidence supports topical clonazepam (rinsed and expectorated, not swallowed) and capsaicin as the most effective local approaches; antidepressants (particularly TCAs and SNRIs) and anticonvulsants may be considered for more persistent central sensitisation [Canfora et al., Journal of Oral and Facial Pain, 2026]. Cognitive behavioural therapy (CBT) has also shown benefit for the pain and psychological burden associated with chronic BMS.

Final Thoughts

Burning mouth syndrome is genuinely one of the more difficult conditions to navigate — not because it’s untreatable, but because it’s under-investigated, poorly understood by most general practitioners, and caused by several very different mechanisms that require different approaches. The frustration many people feel after years of unexplained symptoms and ineffective treatments is entirely valid.

What the recent research makes clear is that LPR deserves serious consideration as a primary driver in BMS — far more serious than it currently gets in standard dental and medical practice. If you have burning mouth symptoms and haven’t been assessed for reflux beyond a standard GERD questionnaire or a course of PPIs, you may not have had a meaningful investigation yet. The failure of PPIs to help doesn’t rule out reflux — as the evidence shows, it’s pepsin and non-acid reflux, not acid alone, that drives the BMS picture in many patients.

Getting dietary management right is the foundation. If you want a structured, LPR-specific plan that addresses the pepsin mechanisms driving oral and throat tissue damage, the Wipeout Diet Plan is built around exactly these principles — it goes well beyond generic reflux advice to address the specific triggers and dietary framework that LPR and pepsin-related symptoms respond to. If you’d like to work through your individual symptom picture in more detail, a one-to-one consultation is available.

Frequently Asked Questions

Can acid reflux really cause burning mouth syndrome?

Yes — and the evidence is stronger than most people (and most doctors) realise. A 2021 prospective study using impedance-pH monitoring found LPR events in 93.8% of patients with primary BMS. The mechanism is pepsin: the digestive enzyme carried up from the stomach in reflux binds to oral mucosal tissue and gets reactivated by dietary acid, causing persistent nerve damage and inflammation that produces the burning sensation.

Why didn’t PPIs help my burning mouth?

PPIs reduce acid production but don’t stop reflux from occurring, and they don’t address weakly acidic or non-acid reflux events — which account for over half of LPR events in BMS patients. They also don’t clear pepsin already deposited in the oral mucosa. This is why the research shows PPIs failing in roughly 60% of BMS-GERD patients, while alginate barrier therapy, which physically limits pepsin exposure, produces more consistent improvement.

How do I know if my BMS is caused by reflux?

Useful signals include: LPR symptoms (throat clearing, hoarseness, chronic cough, globus) alongside oral burning; symptoms that worsen after acidic foods or drinks; a bitter or sour taste in the mouth; worsening after lying down; and failure to respond to standard dental or neuropathic treatments. The RSI questionnaire is a useful screening tool. Formal confirmation requires hypopharyngeal-esophageal impedance-pH monitoring (HEMII-pH) or salivary pepsin testing.

What is salivary pepsin testing and can it diagnose reflux-related BMS?

Salivary pepsin testing (using a product called Peptest) measures the concentration of pepsin in saliva — a direct marker of pharyngeal reflux exposure. A 2024 study found that 86.8% of BMS patients tested positive for salivary pepsin, and that higher pepsin levels correlated with worse burning symptoms. It’s non-invasive and increasingly used as a first-line marker for LPR in BMS patients before committing to full impedance-pH monitoring.

What nutritional deficiencies cause burning mouth syndrome?

The most important ones to test for are iron, zinc, vitamin B1, B2, B6, B12, folate, and vitamin D. All of these play a role in nerve function and oral mucosal integrity. Deficiency in any of them can contribute to the abnormal sensory signalling that produces burning symptoms. Blood testing is the only reliable way to identify this, and deficiencies can co-exist with reflux-related BMS — compounding each other.

Is burning mouth syndrome permanent?

Not necessarily — particularly when the underlying cause is identified and treated. In reflux-driven BMS, 62.5% of patients in the Lechien study reported meaningful improvement in burning scores at three months with appropriate reflux treatment. Primary neuropathic BMS is more variable — some patients experience spontaneous partial remission over time, while others require longer-term management. Early recognition of the underlying cause gives the best chance of resolution.

What’s the difference between burning mouth syndrome and burning tongue?

Burning tongue (glossodynia or glossopyrosis) refers specifically to a burning sensation localised to the tongue. Burning mouth syndrome is the broader diagnosis when burning affects multiple oral sites — tongue, gums, lips, palate, or inner cheeks. The underlying causes and mechanisms are largely the same, and most research uses the terms interchangeably or treats burning tongue as a subtype of BMS.

Related Articles

• The Complete Guide to LPR (Silent Reflux)
• LPR Symptoms: The Complete List
• Why Your Acid Reflux Medication Isn’t Working
• LPR Foods to Avoid for Faster Recovery
• Vitamin D and Silent Reflux
• The Ultimate Guide to Acid Reflux & GERD
• Silent Reflux and Post-Nasal Drip

Research Sources

LPR was detected in 93.8% of 81 primary BMS patients via impedance-pH monitoring; 62.5% reported improvement in mouth and tongue burning following reflux-targeted treatment with diet, PPI, and alginate [Lechien et al., Laryngoscope, 2021]. A scoping review of 18 studies found LPR prevalence in BMS patients of 50%–93.8%, compared to just 3.39%–23.4% for GERD alone, confirming pharyngeal reflux as more clinically relevant than stomach-level acid in BMS [Li et al., Oral Diseases, 2024].

Salivary pepsin positivity reached 86.8% in BMS patients tested with Peptest; patients with higher pepsin concentrations reported significantly worse burning mouth scores, supporting pepsin as a primary mediator [Lechien et al., European Archives of Otorhinolaryngology, 2024]. In BMS patients with confirmed GERD, 60.5% reported no benefit from PPI therapy; alginate and barrier therapy produced improvement in 49.2% of patients, with 28% achieving near-complete remission [Russo et al., Acta Biomedica, 2022].

BMS pathophysiology involves neuropathic pain mechanisms including small-fibre nerve damage and central sensitisation; altered sensory thresholds produce burning from stimuli that would normally be innocuous [Klasser et al., Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017]. BMS prevalence is 0.7%–5% of the population, with highest rates in postmenopausal women aged 50–70; diagnostic delay remains a persistent clinical problem [Mun et al., Journal of Oral Medicine and Pain, 2022]. Topical clonazepam and capsaicin have the strongest current evidence for primary neuropathic BMS; antidepressants, anticonvulsants, and CBT are supported adjuncts for persistent cases [Canfora et al., Journal of Oral and Facial Pain, 2026].